Cervical cytokine responses in women with primary or recurrent chlamydial infection

Journal of Interferon and Cytokine Research

Volumn 27, Issue 3, 2007, Pages 221-226

  Agrawal, Tanvi ^a   Vats, Vikas ^a   Wallace, Paul K ^b   Salhan, Sudha ^a   Mittal, Aruna ^a  

^a SAFDARJUNG HOSPITAL   (India)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ESTRADIOL; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROGESTERONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GYNECOLOGIC DISEASE; HORMONAL REGULATION; HORMONE PROTEIN COMPLEX; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT INFECTION; UTERINE CERVIX CYTOLOGY;

ADULT; CERVIX UTERI; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CYTOKINES; ESTRADIOL; FEMALE; HUMANS; MIDDLE AGED; PROGESTERONE;

CHLAMYDIA TRACHOMATIS;

EID: 33947267483     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2006.0132     Document Type: Article

References (31)

1. West SK, Rapoza P, Munoz B, Taylor HR. Epidemiology of ocular chlamydial infection in a trachoma-hyperendemic area. J. Infect. Dis. 1991;163:752-756.
2. Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzila N, Goeman J, Behets F, Batter V, Alary M. Nonulcerative sexually transmitted diseases as risk factors for HIV 1 transmission in women: results from a cohort study, AIDS (Phila.) 1993;7:95-102.
3. Ho JL, He S, Hu A, Geng J, Basile FG, Almeida MG, Saito AY, Laurence J, Johnson WD Jr. Neutrophils from human immunodeficiency virus (HIV) seronegative donors induce HIV replication from HIV infected patients, mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis. J. Exp. Med. 1995;181:1493-1505.
4. Rank RG, Soderberg LS, Barron AL. Chronic chlamydial genital infection in congenitally athymic nude mice. Infect. Immun. 1985;48:847-849.
5. Buchholz KR, Stephens RS. Activation of the host cell proinflammatory interleukin-8 response by Chlamydia trachomatis. Cell Microbiol. 2006;8:1768-1779.
6. McNeely SG Jr. Pelvic inflammatory disease. Curr. Opin. Obstet. Gynecol. 1992;4:682-686.
7. Parks KS, Dixon PB, Richy CM, Hook EW 3rd. Spontaneous clearance of Chlamydia trachomatis infection in untreated patients. Sex. Transm. Dis. 1997;24:229-235.
8. Grayston JT, Wang SP, Yeh LJ, Kuo CC. Importance of reinfection in the pathogenesis of trachoma. Rev. Infect. Dis. 1985;7:717-725.
9. Stadnyk AW. Cytokine production by epithelial cells. FASEB J. 1994;8:1041-1045.
10. Podoisky DK. Mucosal immunity and inflammation. V. Innate mechanism of mucosal defense and repair: the best offense is a good defense. Am. J. Physiol. 1999;277:G495-499.
11. Patton DL, Rank RG. Animal model for study of pelvic inflammatory disease. In: Quinn TC, ed. Sexually Transmitted Diseases. New York: Raven Press, 1992:85-111.
12. Ito JJI, Harrison R, Alexander ER, Billings LJ. Establishment of genital tract infection in the CF-1 mouse by intravaginal inoculation of a human oculogenital isolate of Chlamydia trachomatis. J. Infect. Dis. 1984;150:577-582.
13. Sweet RL, Blankfort-Doyle M, Robbie MO, Schachter J. The occurrence of chlamydial and gonococcal salpingitis during the menstrual cycle. JAMA 1986;255:2246-2250.
14. Washington AE, Gove S, Schachter J, Sweet RL. Oral contraceptives, Chlamydia trachomatis infection, and pelvic inflammatory disease. A word of caution about protection. JAMA 1985;1985:2062-2065.
15. Rietmeijer CA, Bemmelen R van, Judson FN, Douglas JM Jr. Incidence and increased infection rates of Chlamydia trachomatis among male and female patients in an STD clinic: implications for screening and rescreening. Sex. Transm. Dis. 2002;25:65-72.
16. Lehtinen M, Paavonen J. Heat shock proteins in the immunopathogenesis of chlamydial pelvic inflammatory disease. In: Orfila J, ed. Chlamydial Infections. Proceedings of the Seventh International Symposium on Human Chlamydial Infections. Bologna: Editrice Esculapio, 1994:599-610.
17. Johnson RM. Murine oviduct epithelial cell cytokine responses to Chlamydia muridarum infection include interleukin-12-p70 secretion. Infect. Immun. 2004;72:3951-3960.
18. Darville T, O'Neill JM, Andrews CW Jr, Nagarajan UM, Stahl L, Ojcius DM. Toll like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J. Immunol. 2003;171:6187-6197.
19. Williams DM, Grubbs BG, Darville T, Kelly K, Rank RG. A role for interleukin 6 in host defense against murine Chlamydia trachomatis infection. Infect. Immun. 1998;66:4564-4567.
20. Hanada H, Ikdea-Dantsuji Y, Naito M, Nagayama A. Infection of human fibroblast-like synovial cells with Chlamydia trachomatis results in persistent infection and interleukin-6 production. Microb. Pathol. 2003;34:57-63.
21. Reddy BS, Rastogi S, Salhan S, Verma S, Mittal A. Cytokine expression pattern in the genital tract of Chlamydia trachomatis-positive infertile women-implications for T cell responses. Clin. Exp. Immunol. 2004;137:552-558.
22. Cohen CR, Plummer FA, Mugo M, Maclean I, Shen C, Bukusi EA, Irungu E, Sinei S, Bwayo J, Brunham RC. Increased interleukin 10 in the endocervical secretion of women with nonulcerative sexually transmitted diseases: a mechanism for enhanced HIV-1 transmission? AIDS 1999;13:327-332.
23. Rottenberg ME, Gigliotti RA, Gigliotti D, Ceausu M, Une C, Levitsky V, Wigzell H. Regulation and role of IFN-gamma in the innate resistance to infection with Chlamydia pneumoniae. J. Immunol. 2000;164:4812-4818.
24. Gerard HC, Branigan PJ, Schumacherz HR Jr, Hudson AP. Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J. Rheumatol. 1998;25:734-742.
25. Byrne GI, Krueger DA. Lymphokine mediated inhibition of Chlamydia replication in mouse fibroblasts is neutralized by anti-gamma interferon immunoglobulin Infect. Immun. 1983;42:1152-1158.
26. Byrne GI, Lehmann LK, Landry GJ. Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect. Immun. 1986;53:347-351.
27. Rodel J, Straube E, Lungershausen W, Hartmann M, Groh A. Secretion of cytokines by human synoviocytes during in vitro infection with Chlamydia trachomatis. J. Rheumatol. 1998;11:2161-2168.
28. Jendro MC, Deutsch T, Korber B, Kohler L, Kuipers JG, Krausse-Opatz B, Westermann J, Raum E, Zeidler H. Infection of human monocyte-derived macrophages with Chlamydia trachomatis induces apoptosis of T cells: a potential mechanism for persistent infection. Infect. Immun. 2000;68:6704-6711.
29. Carlin JM, Weller JB. Potentiation of interferon mediated inhibition of Chlamydia infection by interleukin 1 in human macrophage cultures. Infect. Immun. 1995;63:1870-1875.
30. Kaushic C, Murdin AD, Underdown BJ, Wira CR. Chlamydia trachomatis infection in the female reproductive tract of the rat: influence of progesterone on infectivity and immune response. Infect. Immun. 1998;66:893-898.
31. Bose SK, Goswami PC. Enhancement of adherence and growth of Chlamydia trachomatis by estrogen treatment of HeLa cells. Infect. Immun. 1986;53:646-650.